DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66(4):290–308
Article
PubMed
Google Scholar
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85
Article
CAS
PubMed
Google Scholar
Torgovnick A, Schumacher B (2015) DNA repair mechanisms in cancer development and therapy. Front Genet 6:157
Article
PubMed
PubMed Central
Google Scholar
Broustas CG, Lieberman HB (2014) DNA damage response genes and the development of cancer metastasis. Radiat Res 181(2):111–130
Article
CAS
PubMed
PubMed Central
Google Scholar
Markowitz SD, Bertagnolli MM (2009) Molecular basis of colorectal cancer. N Engl J Med 361(25):2449–2460
Article
CAS
PubMed
PubMed Central
Google Scholar
Tiwari V, Wilson DM III (2019) DNA damage and associated DNA repair defects in disease and premature aging. Am J Hum Genet 105(2):237–257
Article
CAS
PubMed
PubMed Central
Google Scholar
Bernstein C, Bernstein H, Payne CM, Garewal H (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511(2):145–178
Article
CAS
PubMed
Google Scholar
Consortium CBCC-C (2004) CHEK2* 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74(6):1175–1182
Article
Google Scholar
Cybulski C, Gorski B, Huzarski T, Masojć B, Mierzejewski M, Dębniak T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131–1135
Article
CAS
PubMed
PubMed Central
Google Scholar
de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G et al (2005) Colorectal cancer and the CHEK2 1100delC mutation. Genes Chromosomes Cancer 43(4):377–382
Article
PubMed
Google Scholar
Bartkova J, Hořejší Z, Koed K, Krämer A, Tort F, Zieger K et al (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434(7035):864–870
Article
CAS
PubMed
Google Scholar
Williams LH, Choong D, Johnson SA, Campbell IG (2006) Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers. Clin Cancer Res 12(23):6967–6972
Article
CAS
PubMed
Google Scholar
Kilpivaara O, Vahteristo P, Falck J, Syrjäkoski K, Eerola H, Easton D et al (2004) CHEK2 variant I157T may be associated with increased breast cancer risk. IJC 111(4):543–547
CAS
Google Scholar
Li J, Williams BL, Haire LF, Goldberg M, Wilker E, Durocher D et al (2002) Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol Cell 9(5):1045–1054
Article
CAS
PubMed
Google Scholar
Seppälä E, Ikonen T, Mononen N, Autio V, Rökman A, Matikainen M et al (2003) CHEK2 variants associate with hereditary prostate cancer. Br J Cancer 89(10):1966–1970
Article
PubMed
PubMed Central
Google Scholar
Coughtrie M (2002) Sulfation through the looking glass—recent advances in sulfotransferase research for the curious. Pharmacogen J 2(5):297–308
Article
CAS
Google Scholar
Harris R, Picton R, Singh S, Waring R (2000) Activity of phenolsulfotransferases in the human gastrointestinal tract. Life Sci 67(17):2051–2057
Article
CAS
PubMed
Google Scholar
Glatt H (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129(1–2):141–170
Article
CAS
PubMed
Google Scholar
Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z et al (1993) Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1–p11.2 and to mouse chromosome 7. Genomics 18(2):440–443
Article
CAS
PubMed
Google Scholar
Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM (1997) Phenol sulfotransferase pharmacogenetics in humans: association of commonSULT1A1alleles with TS PST phenotype. Biochem Biophys Res Commun 239(1):298–304
Article
CAS
PubMed
Google Scholar
Tumbull R, Kyle K, Watson F, Spratt J (1967) Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 166:420–427
Article
Google Scholar
Gabriel W, Dukes C, Bussey H (1935) Lymphatic spread in cancer of the rectum. BJS 23(90):395–413
Article
Google Scholar
Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Article
CAS
PubMed
PubMed Central
Google Scholar
Cybulski C, Huzarski T, Górski B, Masojć B, Mierzejewski M, Dębniak T et al (2004) A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64(8):2677–2679
Article
CAS
PubMed
Google Scholar
Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomark Prev 10(2):89–94
Google Scholar
Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3(5):421–429
Article
CAS
PubMed
Google Scholar
Antoni L, Sodha N, Collins I, Garrett MD (2007) CHK2 kinase: cancer susceptibility and cancer therapy–two sides of the same coin? Nat Rev Cancer 7(12):925–936
Article
CAS
PubMed
Google Scholar
Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N et al (2007) Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case–control study. Hum Mol Genet 16(15):1794–1801
Article
CAS
PubMed
Google Scholar
Kilpivaara O, Alhopuro P, Vahteristo P, Aaltonen LA, Nevanlinna H (2006) CHEK2 I157T associates with familial and sporadic colorectal cancer. J Med Genet 43(7):e34
Article
CAS
PubMed
PubMed Central
Google Scholar
Kleibl Z, Havranek O, Novotny J, Kleiblova P, Soucek P, Pohlreich P (2008) Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Breast Cancer Res Treat 112(1):159–164
Article
CAS
PubMed
Google Scholar
Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calo V et al (2008) BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110(1):161–167
Article
CAS
PubMed
Google Scholar
Bogdanova N, Enβen-Dubrowinskaja N, Feshchenko S, Lazjuk GI, Rogov YI, Dammann O et al (2005) Association of two mutations in the CHEK2 gene with breast cancer. Int J Cancer Res 116(2):263–266
Article
CAS
Google Scholar
Cybulski C, Wokołorczyk D, Kładny J, Kurzwaski G, Suchy J, Grabowska E et al (2007) Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet 15(2):237–241
Article
CAS
PubMed
Google Scholar
Kleibl Z, Havranek O, Hlavata I, Novotny J, Sevcik J, Pohlreich P et al (2009) The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Eur J Cancer 45(4):618–624
Article
CAS
PubMed
Google Scholar
Konstantinova D, Kadiyska T, Sokolova V, Kaneva R, Mirchev M, Savov A et al (2010) CHEK2 I157T and colorectal cancer in Bulgaria. J BUON 15(2):314–317
CAS
PubMed
Google Scholar
Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273(5281):1516–1517
Article
CAS
PubMed
Google Scholar
Xiao J, Zheng Y, Zhou Y, Zhang P, Wang J, Shen F et al (2014) Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: a meta-analysis of 53 case-control studies. PLoS ONE 9(9):e106774
Article
PubMed
PubMed Central
Google Scholar
Forat-Yazdi M, Jafari M, Kargar S, Abolbaghaei SM, Nasiri R, Farahnak S et al (2017) Association between SULT1A1 Arg213His (Rs9282861) polymorphism and risk of breast cancer: a systematic review and meta-analysis. J Res Health Sci 17(4):e00396
PubMed
Google Scholar
Liang G, Miao X, Zhou Y, Tan W, Lin D (2004) A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 25(5):773–778
Article
CAS
PubMed
Google Scholar
Wong CF, Liyou N, Leggett B, Young J, Johnson A, McManus ME (2002) Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 29(9):754–758
Article
CAS
PubMed
Google Scholar
Bidwell LM, McManus ME, Gaedigk A, Kakuta Y, Negishi M, Pedersen L et al (1999) Crystal structure of human catecholamine sulfotransferase. J Mol Biol 293(3):521–530
Article
CAS
PubMed
Google Scholar
Zhang C, Li J-P, Lv G-Q, Yu X-M, Gu Y-L, Zhou P (2011) Lack of association of SULT1A1 R213H polymorphism with colorectal cancer: a meta-analysis. PLoS ONE 6(6):e19127
Article
CAS
PubMed
PubMed Central
Google Scholar